Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has opened the reporting season for Israeli companies by publishing its fourth quarter and full-year 2024 financial results.

JERUSALEM (JTA) — Israel-based Teva Pharmaceutical Industries, one of the largest manufacturers of generic drugs in the world, will lay off 14,000 workers as part of a global restructuring ...

U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...

1 Day TEVA -5.67% DJIA -0.28% S&P 500 -0.76% Health Care/Life Sciences 0.29% ...

Sound Shore Management emphasized stocks such as Teva Pharmaceutical Industries Limited (NYSE:TEVA). Headquartered in Tel Aviv, Israel, Teva Pharmaceutical Industries Limited (NYSE:TEVA ...

The company will report earnings before the open on Jan. 29 Israel-based pharmaceutical giant Teva Pharmaceutical Industries Ltd (NYSE:TEVA) is preparing for its latest quarterly earnings report ...

31 (UPI) --The European Commission fined Teva Pharmaceuticals $503 million for ... The multinational drug manufacturer ...

On January 10, 2025, Teva Pharmaceutical Industries Ltd. and Samsung ... Formycon’s aflibercept biosimilar, in Israel and most of Europe. This agreement expands Teva’s partnership with ...

Teva Pharmaceutical Indus 30-Day Option Volume & Interest Snapshot Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its ...

Sound Shore Management emphasized stocks such as Teva Pharmaceutical Industries Limited (NYSE:TEVA). Headquartered in Tel Aviv, Israel, Teva Pharmaceutical Industries Limited (NYSE:TEVA) engages in ...